4-Bromo-2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione
PG-20161-44846
CAS 2851889-86-4MW 355.1
Same subcategory
4-Bromo-2-(2,6-dioxopiperidin-3-yl)-7-fluoroisoindoline-1,3-dione
PG-20161-71351
Product information
- Catalog No.
- PG-20161-71351
- Product Name
- 4-Bromo-2-(2,6-dioxopiperidin-3-yl)-7-fluoroisoindoline-1,3-dione
- CAS No.
- 2740657-30-9
- Molecular Formula
- C13H8BrFN2O4
- Molecular Weight
- 355.1
- Purity
- Not specified
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-71351 | 50 MG | USD 133 | In stock | |
| PG-20161-71351 | 100 MG | USD 225 | In stock | |
| PG-20161-71351 | 250 MG | USD 383 | In stock |
Prices are shown in USD. Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- 4-Bromo-2-(2,6-dioxopiperidin-3-yl)-7-fluoroisoindoline-1,3-dione
- CAS No.
- 2740657-30-9
- Synonyms
- Not specified
- Molecular Formula
- C13H8BrFN2O4
- Molecular Weight
- 355.1
- Appearance
- Not specified
- Solubility
- Not specified
- Description
4-Bromo-2-(2,6-dioxopiperidin-3-yl)-7-fluoroisoindoline-1,3-dione is a bromine- and fluorine-containing E3 ligase activator listed among thalidomide-based ligands in the PROTAC linker catalog. E3 ligases participate in ubiquitin labeling of proteins for degradation. The two halogen substituents offer potential sites for further derivatization through substitution. This reagent-grade compound is intended for laboratory research only. Its molecular formula is C13H8BrFN2O4, and its molecular weight is 355.1.